Longboard Pharmaceuticals, Inc. Common Stock
LBPH
LBPH was delisted on the 29th of November, 2024.
52 hedge funds and large institutions have $99.9M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 6 closing their positions.
130% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 10
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
15% more capital invested
Capital invested by funds: $87.1M → $99.9M (+$12.8M)
2% more funds holding
Funds holding: 51 → 52 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$2.4M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.32M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.5M |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$698K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$633K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.31M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$1.79M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$724K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$693K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$452K |
LBPH Hedge Fund Activity: Q4 2023 in Review
52 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q4 2023, worth a combined $99.9M — up 15% from $87.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LBPH positions and 6 closed out — a net gain of 1 holder — while 23 added to existing stakes and 10 trimmed.
The largest buyer was Jennison Associates, opening a new position worth an estimated $2.4M. The largest seller was Fidelity Investments, cutting an estimated $2.31M.
- 52 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q4 2023, up from 51 in Q3 2023.
- Funds reported $99.9M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q4 2023, up 15% quarter-over-quarter.
- 7 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q4 2023 and 6 closed out, a net change of +1 holder.
- The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q4 2023 was Jennison Associates, an estimated $2.4M added.
- The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q4 2023 was Fidelity Investments, an estimated $2.31M sold.
Based on aggregated 13F filings for Q4 2023.